The Scientist

» disease/medicine, evolution and microbiology

Most Recent

image: Get a Whiff of This

Get a Whiff of This

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

2 Comments

image: The Leprosy Bacillus, circa 1873

The Leprosy Bacillus, circa 1873

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

0 Comments

image: Three-Way Parenthood

Three-Way Parenthood

By , and | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

2 Comments

image: Trouble in the Heartland

Trouble in the Heartland

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

0 Comments

image: Yoav Gilad: Gene Regulator

Yoav Gilad: Gene Regulator

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

3 Comments

image: Smell and the Degenerating Brain

Smell and the Degenerating Brain

By | October 1, 2013

An issue devoted to the latest research on how smells lead to actions

7 Comments

image: Week in Review: September 23–27

Week in Review: September 23–27

By | September 27, 2013

An issue devoted to the latest research on how smells lead to actions

0 Comments

image: Different Cancers, Same Mutations

Different Cancers, Same Mutations

By | September 26, 2013

An issue devoted to the latest research on how smells lead to actions

4 Comments

image: Giving Antibiotic Cycling Another Shot

Giving Antibiotic Cycling Another Shot

By | September 25, 2013

An issue devoted to the latest research on how smells lead to actions

2 Comments

image: Citations Predict Nobel Winners?

Citations Predict Nobel Winners?

By | September 25, 2013

An issue devoted to the latest research on how smells lead to actions

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech